Beware! Coloring your hair can up chances of breast cancer

stewartdean98 · Mar 12, 2017

Women beware before dying your hair or using hormonal contraceptives, as they may increase your chances of breast cancer.

Researcher Sanna Heikkinen from the University of Helsinki in Finland and Finnish Cancer Registry evaluated the contribution of the use of hormonal contraceptives and hair dyes on breast cancer risk factors.

"The biggest risk factor in breast cancer is high age and known lifestyle-related risk factors include late age at first birth, small number of children, high alcohol consumption and sedentary lifestyle," said Heikkinen.

They analysed self-reported survey data from 8,000 breast cancer patients and 20,000 controls from Finland.

The results suggested that use of other hormonal contraceptives was, by contrast, associated with 32 percent higher breast cancer risk among younger women under 50 when compared to women who did not use hormonal contraceptives.

The team also investigated the amount of opportunistic mammography, which was found to be very common.

More than 60 percent of responders reported having had a mammography before the screening age of 50. Read the full story here.

Maccabee · Mar 26, 2017

That may be why SJW feminists think the way they do.

Sallyally · Mar 27, 2017

stewartdean98 said: ↑

Women beware before dying your hair or using hormonal contraceptives, as they may increase your chances of breast cancer.

Researcher Sanna Heikkinen from the University of Helsinki in Finland and Finnish Cancer Registry evaluated the contribution of the use of hormonal contraceptives and hair dyes on breast cancer risk factors.

"The biggest risk factor in breast cancer is high age and known lifestyle-related risk factors include late age at first birth, small number of children, high alcohol consumption and sedentary lifestyle," said Heikkinen.

They analysed self-reported survey data from 8,000 breast cancer patients and 20,000 controls from Finland.

The results suggested that use of other hormonal contraceptives was, by contrast, associated with 32 percent higher breast cancer risk among younger women under 50 when compared to women who did not use hormonal contraceptives.

The team also investigated the amount of opportunistic mammography, which was found to be very common.

More than 60 percent of responders reported having had a mammography before the screening age of 50. Read the full story here.
Click to expand...

What effect does hair dye have on men?

waltky · Jan 1, 2018

New Tool to Detect Breast Cancer...

Radiologists Have a New Tool to Detect Breast Cancer
December 29, 2017 | WASHINGTON — Breast cancer is the most common cancer in women worldwide, and early detection saves lives.

Scientists are working on finding new ways to detect breast cancer while at the same time they are studying existing screening methods to find out what is best. Take, for example, mammograms. During a mammogram, a technician takes an X-ray of a woman’s breast as it’s compressed between two glass plates. A radiologist then examines the image for tumors. They are the best screening tools available: The number of deaths from breast cancer has fallen by 30 percent in the U.S. since mammography was introduced in the 1970s. That’s because when cancer is found early, the chances of beating it are greater. But mammograms aren’t 100 percent accurate. A mammogram can look normal even when cancer is present, and it can look abnormal even though there’s no cancer in the breast at all.

3-D mammography

Standard mammograms are two dimensional, but for the 40 to 50 percent of women with dense breasts, both tumors and breast tissue can show up as white masses on 2-D images. Three-dimensional mammograms show a more detailed view of the breast, so women with fibrous or dense breasts may benefit from a 3-D screening, said Dr. Otis Brawley at the American Cancer Society. “It might find disease that we need to find that two-dimensional does not,” he said. “There are potential cons in that it has a higher cost, higher amount of radiation, given every dose, every time a person has a test, as well as it may find a higher number of false positives.” Cost aside, one study involving 13 U.S. hospitals showed that three-dimensional mammograms picked up an additional 40 percent of invasive cancers.

Ultrasound

For an even better picture, a woman could have an automated whole-breast ultrasound. During this procedure, a woman lies on her back as the ultrasound device moves in parallel rows so no areas of the breast are missed. The exam captures between 3,000 to 5,000 images that are then interpreted by a radiologist. Dr. Megha Garg is the director of the breast-imaging program at the University of Missouri cancer center. “This is a new screening technique,” she said. “It helps detect additional breast cancers in females who have dense breasts.”

The whole-breast ultrasound doesn’t use radiation, so it poses less of a risk than a mammogram does, but Garg says it’s not time to ditch the standard mammogram. “This tool does not replace the traditional mammogram. Mammograms are the gold standard for finding breast cancer,” she said. “This helps the mammogram in those females who have dense breasts. Studies are underway to find out which techniques are the most effective. While North America, Western Europe and Australia have the highest rates of breast cancer, the World Health Organization reports that almost 50 percent of the cases and nearly 60 percent of the deaths occur in less-developed countries. If detection and treatment could be improves, at least 400,000 women’s lives could be saved every year.

https://www.voanews.com/a/new-tool-to-detect-breast-cancer/4184001.html
Click to expand...

waltky · May 17, 2018

Shorter Drug Treatment OK for Many Breast Cancer Patients...

Shorter Drug Treatment OK for Many Breast Cancer Patients
May 16, 2018 - Many women with a common and aggressive form of breast cancer that is treated with Herceptin can get by with six months of the drug instead of the usual 12, greatly reducing the risk of heart damage it sometimes can cause, a study suggests.

It's good news, but it comes nearly two decades after the drug first went on the market and many patients have suffered that side effect. The study was done in the United Kingdom and funded by UK government grants. Results were released Wednesday by the American Society of Clinical Oncology and will be presented at the group's meeting next month. Herceptin transformed care of a dreaded disease when it was approved in 1998 for women with advanced breast cancers whose growth is aided by a faulty HER2 gene, as 15 percent to 20 percent of cases are. It was later approved for treatment of those cancers in earlier stages, too, based on studies that had tested it in patients for 12 months. That guess, that the drug should be taken for a year, became the standard of care.

A radiologist uses a magnifying glass to check mammograms for breast cancer in Los Angeles, California

But the drug can hurt the heart's ability to pump. That often eases if treatment is stopped but the damage can be permanent and lead to heart failure. Some studies tested shorter use, but results conflicted. The new study is the largest so far, and involved more than 4,000 women with early-stage cancers who were given usual chemotherapy plus Herceptin for either six or 12 months. After four years, about 90 percent of both groups were alive without signs of the disease. Only 4 percent on the shorter treatment dropped out due to heart problems versus 8 percent of those treated for a year. “It's great news” for patients, said the study leader, Dr. Helena Earl of the University of Cambridge in England. Earl has consulted for Herceptin's maker, Roche. The company had no role in the study.

Compelling findings

“There's no reason to not immediately change practice. The findings are persuasive,” said Dr. Richard Schilsky, chief medical officer for the oncology society. Most of Herceptin's cancer-fighting benefit seems to come in the early months of use, he said. Others said that because so few women have died or relapsed after being treated with the drug, longer followup may be needed to make sure the findings hold up before guidelines should be changed. Doctors also want to see results published, and to study them to see if certain groups of women need longer treatment. Herceptin is given through an IV every three weeks; a year of it costs $34,000 to $40,000 in England and about $70,000 in the U.S. In December, a copycat competitor known as a biosimilar was approved in the U.S. and already is used in some other countries. Dr. Harold Burstein, a breast cancer expert at Dana-Farber Cancer Institute in Boston, said shorter treatment may increase access to the drug in countries where many women can't afford it now, but that in the U.S., “my guess is that people will continue to aim for a year of treatment” because of lingering concerns that longer use is better, as a smaller, previous study suggested.

Chemotherapy drugs are administered to a patient at North Carolina Cancer Hospital in Chapel Hill, North Carolina, May 25, 2017. Health experts are stepping up warnings as more cardiac side effects of some breast cancer treatments come to light.

Dr. Jennifer Litton, a breast specialist at MD Anderson Cancer Center in Houston, said Herceptin was a true breakthrough, but scaling back treatment whenever possible is just as important to patients. She said the results show how important it can be to study drugs already on the market, and that drug companies alone should not be relied on to do studies like this. “It's really important that we continue to have public funding for trials so we can continue to ask all of these questions for our patients,” she said. Herceptin's developer, Genentech, now part of Roche, said in a statement that the new study must be viewed along with several smaller previous ones that found one year to be best. The goal of treatment “is to provide people with the best chance for a cure,” so women need to talk with their doctors about how best to reach that goal, the statement says. Earlier this year, the American Heart Association issued its first statement on the heart effects of cancer drugs, saying women should consider carefully the risks and benefits of any therapies that may hurt hearts.

https://www.voanews.com/a/shorter-drug-treatment-ok-for-many-breast-cancer-patients/4397222.html
Click to expand...

DoctorWho · Jun 16, 2018

Sallyally said: ↑

What effect does hair dye have on men?
Click to expand...

Men can also get breast cancer, as Men also have undeveloped breasts, there is a hormonal link to breast cancer, and most men are not at risk, there are genetic risk factors involved as well.

Log in or Sign up

Beware! Coloring your hair can up chances of breast cancer

stewartdean98 Member

Maccabee Well-Known Member

Sallyally Well-Known Member Donor

waltky Well-Known Member

waltky Well-Known Member

DoctorWho Well-Known Member

Share This Page

Log in or Sign up

Beware! Coloring your hair can up chances of breast cancer

stewartdean98 Member

Maccabee Well-Known Member

Sallyally Well-Known Member Donor

waltky Well-Known Member

waltky Well-Known Member

DoctorWho Well-Known Member

Share This Page

Useful Searches